Advanced search
Publication Cover
Clinical, Cosmetic and Investigational Dermatology Volume 16, 2023 - Issue
Submit an article Journal homepage
333
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

12-Week, Single-Center Study of a Targeted Pigment-Correcting Dark Spot Treatment for Post-Inflammatory Hyperpigmentation and Solar Lentigines

Elizabeth T Makino1 SkinMedica - Allergan Aesthetics, an AbbVie Company, Irvine, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6243-861XView further author information
ORCID Icon,
Priscilla Huang1 SkinMedica - Allergan Aesthetics, an AbbVie Company, Irvine, CA, USAORCID Iconhttps://orcid.org/0009-0004-9971-2928View further author information
ORCID Icon,
Tsing Cheng1 SkinMedica - Allergan Aesthetics, an AbbVie Company, Irvine, CA, USAORCID Iconhttps://orcid.org/0000-0001-5191-3289View further author information
ORCID Icon,
Summer F Acevedo2 SGS Stephens Inc, Richardson, TX, USAView further author information
,
Cristiane de Oliveira2 SGS Stephens Inc, Richardson, TX, USAView further author information
&
Rahul C Mehta1 SkinMedica - Allergan Aesthetics, an AbbVie Company, Irvine, CA, USAORCID Iconhttps://orcid.org/0000-0002-7613-5847View further author information
ORCID Icon
Pages 2677-2686 | Received 22 Jul 2023, Accepted 14 Sep 2023, Published online: 27 Sep 2023

References

  • Nautiyal A, Wairkar S. Management of hyperpigmentation: current treatments and emerging therapies. Pigm Cell Melanoma Res. 2021;34(6):1000–1014. doi:10.1111/pcmr.12986
  • Plensdorf S, Livieratos M, Dada N. Pigmentation disorders: diagnosis and management. Am Fam Physician. 2017;96(12):797–804.
  • Davis EC, Callender VD. Postinflammatory hyperpigmentation a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20–31.
  • Makino ET, Kadoya K, Sigler ML, Hino PD, Mehta RC. Development and clinical assessment of a comprehensive product for pigmentation control in multiple ethnic populations. J Drugs Dermatol. 2016;15(12):1562–1570.
  • Scarcella G, Gerber PA, Edge D, Nielsen MCE. Effective removal of solar lentigines by combination of pre– and post–fluorescent light energy treatment with picosecond laser treatment. Clin Case Rep. 2020;8(8):1429–1432. doi:10.1002/ccr3.2839
  • Kang BY, Ibrahim SA, Shokeen D, et al. Postinflammatory hyperpigmentation: protocol for development of a core outcome set for clinical trials. Arch Dermatol Res. 2022;314(4):357–361. doi:10.1007/s00403-021-02239-6
  • Perkins AC, Cheng CE, Hillebrand GG, et al. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J Eur Acad Dermatol. 2011;25(9):1054–1060. doi:10.1111/j.1468-3083.2010.03919.x
  • Markiewicz E, Idowu OC. Melanogenic difference consideration in ethnic skin type: a balance approach between skin brightening applications and beneficial sun exposure. Clin Cosmet Invest Dermatol. 2020;13:215–232. doi:10.2147/CCID.S245043
  • Vashi NA, de Castro Maymone MB, Kundu RV. Aging differences in ethnic skin. J Clin Aesthet Dermatol. 2016;9(1):31–38.
  • Ortonne JP. Pigmentary changes of the ageing skin. Brit J Dermatol. 1990;122(s35):21–28. doi:10.1111/j.1365-2133.1990.tb16121.x
  • Szymańczyk J, Trzeciakowski W, Ivonyak Y, et al. Blue laser (450 nm) treatment of solar lentigines. J Clin Med. 2021;10(21):4919. doi:10.3390/jcm10214919
  • Anvery N, Christensen RE, Dirr MA. Management of post‐inflammatory hyperpigmentation in skin of color: a short review. J Cosmet Dermatol. 2022;21(5):1837–1840. doi:10.1111/jocd.14916
  • Balkrishnan R, McMichael AJ, Hu JY, et al. Correlates of health‐related quality of life in women with severe facial blemishes. Int J Dermatol. 2006;45(2):111–115. doi:10.1111/j.1365-4632.2004.02371.x
  • Plensdorf S, Martinez J. Common pigmentation disorders. Am Fam Physician. 2009;79(2):109–116.
  • Shenoy A, Madan R. Post-inflammatory hyperpigmentation: a review of treatment strategies. J Drugs Dermatol. 2020;19(8):763–768. doi:10.36849/JDD.2020.4887
  • Hu S, Atmakuri M, Rosenberg J. Adverse events of nonablative lasers and energy-based therapies in subjects with Fitzpatrick skin phototypes IV to VI: a systematic review and meta-analysis. Aesthet Surg J. 2021;42(5):537–547. doi:10.1093/asj/sjab398
  • Trivedi MK, Yang FC, Cho BK. A review of laser and light therapy in melasma. Int J Womens Dermatol. 2017;3(1):11–20. doi:10.1016/j.ijwd.2017.01.004
  • Kang M, Park SH, Park SJ, et al. p44/42 MAPK signaling is a prime target activated by phenylethyl resorcinol in its anti-melanogenic action. Phytomedicine. 2019;58:152877. doi:10.1016/j.phymed.2019.152877
  • Konisky H, Balazic E, Jaller JA, Khanna U, Kobets K. Tranexamic acid in melasma: a focused review on drug administration routes. J Cosmet Dermatol. 2023;22(4):1197–1206. doi:10.1111/jocd.15589
  • Searle T, Al‐Niaimi F, Ali FR. The top 10 cosmeceuticals for facial hyperpigmentation. Dermatol Ther. 2020;33(6):e14095. doi:10.1111/dth.14095
  • Sharad J. Glycolic acid peel therapy – a current review. Clin Cosmet Invest Dermatol. 2013;6:281–288. doi:10.2147/CCID.S34029

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.